Class information for:
Level 1: FACTOR VIII//FACTOR VIII INHIBITOR//ACQUIRED HEMOPHILIA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1130 2737 33.3 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
618 13204 HAEMOPHILIA//HAEMOPHILIA A//VON WILLEBRAND DISEASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FACTOR VIII Author keyword 189 33% 17% 474
2 FACTOR VIII INHIBITOR Author keyword 148 79% 4% 96
3 ACQUIRED HEMOPHILIA Author keyword 138 83% 3% 78
4 ACQUIRED HAEMOPHILIA Author keyword 132 82% 3% 77
5 FACTOR VIII INHIBITORS Author keyword 121 79% 3% 78
6 HAEMOPHILIA A Author keyword 91 34% 8% 217
7 IMMUNE TOLERANCE INDUCTION Author keyword 85 79% 2% 54
8 HEMOPHILIA A Author keyword 79 33% 7% 199
9 ACQUIRED HEMOPHILIA A Author keyword 61 82% 1% 36
10 HAEMOPHILIA Journal 61 14% 15% 400

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 FACTOR VIII 189 33% 17% 474 Search FACTOR+VIII Search FACTOR+VIII
2 FACTOR VIII INHIBITOR 148 79% 4% 96 Search FACTOR+VIII+INHIBITOR Search FACTOR+VIII+INHIBITOR
3 ACQUIRED HEMOPHILIA 138 83% 3% 78 Search ACQUIRED+HEMOPHILIA Search ACQUIRED+HEMOPHILIA
4 ACQUIRED HAEMOPHILIA 132 82% 3% 77 Search ACQUIRED+HAEMOPHILIA Search ACQUIRED+HAEMOPHILIA
5 FACTOR VIII INHIBITORS 121 79% 3% 78 Search FACTOR+VIII+INHIBITORS Search FACTOR+VIII+INHIBITORS
6 HAEMOPHILIA A 91 34% 8% 217 Search HAEMOPHILIA+A Search HAEMOPHILIA+A
7 IMMUNE TOLERANCE INDUCTION 85 79% 2% 54 Search IMMUNE+TOLERANCE+INDUCTION Search IMMUNE+TOLERANCE+INDUCTION
8 HEMOPHILIA A 79 33% 7% 199 Search HEMOPHILIA+A Search HEMOPHILIA+A
9 ACQUIRED HEMOPHILIA A 61 82% 1% 36 Search ACQUIRED+HEMOPHILIA+A Search ACQUIRED+HEMOPHILIA+A
10 FVIII INHIBITORS 50 77% 1% 34 Search FVIII+INHIBITORS Search FVIII+INHIBITORS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FACTOR VIII INHIBITORS 383 75% 10% 274
2 PORCINE FACTOR VIII 313 76% 8% 221
3 COAGULATION FACTOR VIII 264 62% 10% 276
4 RECOMBINANT FACTOR VIII 227 57% 10% 272
5 A1 A3 C1 C2 DIMER 134 93% 2% 51
6 HEMOPHILIA A PATIENTS 125 62% 5% 129
7 PREVIOUSLY UNTREATED PATIENTS 98 33% 9% 249
8 HEMOPHILIA A 96 24% 13% 353
9 ANTI FACTOR VIII 90 96% 1% 27
10 FACTOR IX INHIBITORS 85 50% 4% 121

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HAEMOPHILIA 61 14% 15% 400

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A 2009 113 76 76%
Management of acquired haemophilia A 2011 39 75 85%
Genetic risk factors for inhibitors in haemophilia A 2015 1 21 100%
Acquired hemophilia A: Diagnosis, aetiology, clinical spectrum and treatment options 2011 28 56 96%
Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors 2003 198 88 77%
FVIII inhibitors: pathogenesis and avoidance 2015 1 69 84%
Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity 2015 1 85 82%
Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: A critical systematic review 2012 23 86 87%
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis 2012 62 59 37%
The Multifactorial Etiology of Inhibitor Development in Hemophilia: Genetics and Environment 2009 50 83 80%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PLASMA PROT 14 30% 1.5% 41
2 PLASMA PROT TECHNOL 8 70% 0.3% 7
3 HAEMOPHILIA 8 13% 2.2% 60
4 EXPT HAEMATOL TRANSFUS MED 6 18% 1.2% 32
5 ACCUEIL TRAITEMENT HEMOPHILES 6 80% 0.1% 4
6 ZENTRAL OR GERINNUNGSAMBULANZ 6 100% 0.1% 4
7 VAN CREVELD 5 63% 0.2% 5
8 HOLLAND 5 12% 1.4% 38
9 COAGULAT THROMBOSIS UNIT 4 75% 0.1% 3
10 HAEMATOL VASC DIS 4 75% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000177215 FACTOR VIII GENE//F8 GENE//INTRON 22 INVERSION
2 0.0000176886 ASSAY DISCREPANCIES//HEMOPHILIA TREATMENT//FACTOR VIII CONCENTRATE
3 0.0000154710 RFVIIA//RECOMBINANT ACTIVATED FACTOR VII//RECOMBINANT FACTOR VIIA
4 0.0000147228 HAEMOPHILIA//VAN CREVELDKLIN//HEMOPHILIA
5 0.0000108931 FACTOR V DEFICIENCY//FACTOR VA//FACTOR V
6 0.0000059975 THROMBIN GENERATION//SYN SE BV//PHYS BIOCHEM BLOOD
7 0.0000055079 VON WILLEBRAND DISEASE//VON WILLEBRAND FACTOR//VWD
8 0.0000043776 SKIN GENE THERAPY//HUMAN CLOTTING FACTOR IX//CLOTTING FACTOR IX
9 0.0000041576 DESMOPRESSIN//DDAVP//PHARMACOLOGY DESMOPRESSIN
10 0.0000041346 ACQUIRED VON WILLEBRAND SYNDROME//ACQUIRED VON WILLEBRAND DISEASE//ACQUIRED VON WILLEBRANDS SYNDROME